Ozon Pharmaceuticals is launching a new over-the-counter drug, Netugast, based on trimebutin. It is designed to eliminate pain, cramps and discomfort in the abdomen associated with functional disorders of the gastrointestinal tract and biliary tract. First 50,000 packages will be shipped to distributors in early November 2025. By the spring of 2026, the drug will be available in half of the country's pharmacies.